Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
29.39 -0.46 (-1.54%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 29.39 unch (unch) 16:40 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
29.01
Day High
30.53
Open 29.85
Previous Close 29.85 29.85
Volume 427,800 427,800
Avg Vol 465,260 465,260
Stochastic %K 47.46% 47.46%
Weighted Alpha -24.72 -24.72
5-Day Change -0.76 (-2.52%) -0.76 (-2.52%)
52-Week Range 27.27 - 42.29 27.27 - 42.29
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 939,857
  • Shares Outstanding, K 31,486
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 167 M
  • EBITDA $ 334 M
  • 60-Month Beta 0.99
  • Price/Sales 1.48
  • Price/Cash Flow 2.41
  • Price/Book 4.19

Options Overview Details

View History
  • Implied Volatility 64.14% ( +8.53%)
  • Historical Volatility 25.60%
  • IV Percentile 70%
  • IV Rank 64.95%
  • IV High 83.66% on 05/21/24
  • IV Low 27.97% on 09/20/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 390
  • Open Int (30-Day) 546

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.34
  • Number of Estimates 4
  • High Estimate 1.52
  • Low Estimate 1.20
  • Prior Year 1.32
  • Growth Rate Est. (year over year) +1.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.27 +7.75%
on 03/05/25
Period Open: 29.05
30.84 -4.70%
on 03/24/25
+0.34 (+1.17%)
since 02/28/25
3-Month
27.27 +7.75%
on 03/05/25
Period Open: 28.65
34.06 -13.72%
on 01/10/25
+0.74 (+2.58%)
since 12/31/24
52-Week
27.27 +7.75%
on 03/05/25
Period Open: 38.88
42.29 -30.50%
on 10/07/24
-9.49 (-24.41%)
since 04/01/24

Most Recent Stories

More News
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

COLL : 29.39 (-1.54%)
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

COLL : 29.39 (-1.54%)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

BHVN : 22.60 (-5.99%)
COLL : 29.39 (-1.54%)
TRVI : 6.01 (-4.45%)
AVTX : 6.85 (-14.48%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 31.17 (+0.13%)
COLL : 29.39 (-1.54%)
SUPN : 31.68 (-3.27%)
OGN : 14.13 (-5.10%)
ZTS : 161.91 (-1.66%)
Collegium Announces Updates to its Board of Directors and Executive Leadership Team

COLL : 29.39 (-1.54%)
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

COLL : 29.39 (-1.54%)
Collegium to Participate in Upcoming Investor Conferences

COLL : 29.39 (-1.54%)
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 29.39 (-1.54%)
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%

COLL : 29.39 (-1.54%)
Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

COLL : 29.39 (-1.54%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 31.80
2nd Resistance Point 31.16
1st Resistance Point 30.27
Last Price 29.39
1st Support Level 28.75
2nd Support Level 28.12
3rd Support Level 27.23

See More

52-Week High 42.29
Fibonacci 61.8% 36.55
Fibonacci 50% 34.78
Fibonacci 38.2% 33.01
Last Price 29.39
52-Week Low 27.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies